ImmuCell Gross Margin 2010-2025 | ICCC
Current and historical gross margin for ImmuCell (ICCC) over the last 10 years. The current gross profit margin for ImmuCell as of June 30, 2025 is %.
| ImmuCell Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-06-30 | $0.03B | $0.01B | 39.29% |
| 2025-03-31 | $0.03B | $0.01B | 33.33% |
| 2024-12-31 | $0.03B | $0.01B | 30.77% |
| 2024-09-30 | $0.02B | $0.01B | 26.09% |
| 2024-06-30 | $0.02B | $0.01B | 22.73% |
| 2024-03-31 | $0.02B | $0.01B | 23.81% |
| 2023-12-31 | $0.02B | $0.00B | 17.65% |
| 2023-09-30 | $0.02B | $0.00B | 18.75% |
| 2023-06-30 | $0.02B | $0.00B | 25.00% |
| 2023-03-31 | $0.02B | $0.01B | 31.25% |
| 2022-12-31 | $0.02B | $0.01B | 42.11% |
| 2022-09-30 | $0.02B | $0.01B | 50.00% |
| 2022-06-30 | $0.02B | $0.01B | 50.00% |
| 2022-03-31 | $0.02B | $0.01B | 47.62% |
| 2021-12-31 | $0.02B | $0.01B | 47.37% |
| 2021-09-30 | $0.02B | $0.01B | 44.44% |
| 2021-06-30 | $0.02B | $0.01B | 47.06% |
| 2021-03-31 | $0.02B | $0.01B | 46.67% |
| 2020-12-31 | $0.02B | $0.01B | 43.75% |
| 2020-09-30 | $0.02B | $0.01B | 43.75% |
| 2020-06-30 | $0.02B | $0.01B | 40.00% |
| 2020-03-31 | $0.02B | $0.01B | 40.00% |
| 2019-12-31 | $0.01B | $0.01B | 42.86% |
| 2019-09-30 | $0.01B | $0.01B | 38.46% |
| 2019-06-30 | $0.01B | $0.01B | 41.67% |
| 2019-03-31 | $0.01B | $0.01B | 41.67% |
| 2018-12-31 | $0.01B | $0.00B | 36.36% |
| 2018-09-30 | $0.01B | $0.00B | 36.36% |
| 2018-06-30 | $0.01B | $0.00B | 36.36% |
| 2018-03-31 | $0.01B | $0.00B | 40.00% |
| 2017-12-31 | $0.01B | $0.01B | 45.45% |
| 2017-09-30 | $0.01B | $0.01B | 50.00% |
| 2017-06-30 | $0.01B | $0.01B | 50.00% |
| 2017-03-31 | $0.01B | $0.01B | 50.00% |
| 2016-12-31 | $0.01B | $0.01B | 55.56% |
| 2016-09-30 | $0.01B | $0.01B | 60.00% |
| 2016-06-30 | $0.01B | $0.01B | 70.00% |
| 2016-03-31 | $0.01B | $0.01B | 70.00% |
| 2015-12-31 | $0.01B | $0.01B | 70.00% |
| 2015-09-30 | $0.01B | $0.01B | 66.67% |
| 2015-06-30 | $0.01B | $0.01B | 55.56% |
| 2015-03-31 | $0.01B | $0.01B | 55.56% |
| 2014-12-31 | $0.01B | $0.00B | 50.00% |
| 2014-09-30 | $0.01B | $0.00B | 50.00% |
| 2014-06-30 | $0.01B | $0.00B | 57.14% |
| 2014-03-31 | $0.01B | $0.00B | 66.67% |
| 2013-12-31 | $0.01B | $0.00B | 66.67% |
| 2013-09-30 | $0.01B | $0.00B | 80.00% |
| 2013-06-30 | $0.01B | $0.00B | 80.00% |
| 2013-03-31 | $0.01B | $0.00B | 80.00% |
| 2012-12-31 | $0.01B | $0.00B | 80.00% |
| 2012-09-30 | $0.01B | $0.00B | 80.00% |
| 2012-06-30 | $0.01B | $0.00B | 80.00% |
| 2012-03-31 | $0.01B | $0.00B | 80.00% |
| 2011-12-31 | $0.01B | $0.00B | 80.00% |
| 2011-09-30 | $0.01B | $0.00B | 80.00% |
| 2011-06-30 | $0.01B | $0.00B | 60.00% |
| 2011-03-31 | $0.01B | $0.00B | 60.00% |
| 2010-12-31 | $0.00B | $0.00B | 75.00% |
| 2010-09-30 | $0.00B | $0.00B | 75.00% |
| 2010-06-30 | $0.00B | $0.00B | 100.00% |
| 2010-03-31 | $0.00B | $0.00B | 75.00% |
| 2009-12-31 | $0.00B | $0.00B | 75.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.058B | $0.026B |
| ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM, a human application of its milk-derived passive antibodytechnology for use as an alternative to antibiotics in the treatment and/or prevention of Clostridium difficile-associated diarrhea. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.889B | 27.07 |
| Boston Scientific (BSX) | United States | $156.325B | 37.28 |
| Stryker (SYK) | United States | $149.639B | 30.46 |
| EssilorLuxottica (ESLOY) | France | $141.259B | 0.00 |
| Medtronic (MDT) | Ireland | $119.046B | 16.78 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.750B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.937B | 25.13 |
| ResMed (RMD) | United States | $40.192B | 28.75 |
| Agilent Technologies (A) | United States | $35.696B | 23.06 |
| GE HealthCare Technologies (GEHC) | United States | $33.662B | 15.82 |
| Terumo (TRUMY) | Japan | $26.606B | 31.53 |
| Koninklijke Philips (PHG) | Netherlands | $26.557B | 17.57 |
| Insulet (PODD) | United States | $23.925B | 80.16 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.018B | 13.38 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.402B | 0.00 |
| Baxter (BAX) | United States | $12.681B | 9.80 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.061B | 29.61 |
| Lantheus Holdings (LNTH) | United States | $3.733B | 10.09 |
| Envista Holdings (NVST) | United States | $3.520B | 24.63 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.349B | 14.86 |
| Perrigo (PRGO) | Ireland | $3.266B | 8.16 |
| ICU Medical (ICUI) | United States | $3.151B | 21.45 |
| Haemonetics (HAE) | United States | $2.628B | 11.73 |
| Acuren (TIC) | United States | $2.261B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $2.213B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $2.159B | 46.29 |
| QuidelOrtho (QDEL) | United States | $1.948B | 12.26 |
| Green Thumb Industries (GTBIF) | United States | $1.840B | 79.00 |
| AtriCure (ATRC) | United States | $1.838B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.519B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.503B | 17.74 |
| AdaptHealth (AHCO) | United States | $1.284B | 18.25 |
| Neogen (NEOG) | United States | $1.249B | 19.83 |
| BioLife Solutions (BLFS) | United States | $1.200B | 2505.00 |
| InMode (INMD) | Israel | $0.944B | 8.74 |
| Kestra Medical Technologies (KMTS) | United States | $0.829B | 0.00 |
| Valneva SE (VALN) | France | $0.753B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.740B | 0.00 |
| SNDL (SNDL) | Canada | $0.704B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.618B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.615B | 0.00 |
| ZimVie (ZIMV) | United States | $0.532B | 20.52 |
| Evolus (EOLS) | United States | $0.494B | 0.00 |
| Surmodics (SRDX) | United States | $0.487B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.479B | 16.50 |
| CeriBell (CBLL) | United States | $0.434B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.432B | 0.00 |
| Owens & Minor (OMI) | United States | $0.379B | 3.36 |
| Sanuwave Health (SNWV) | United States | $0.357B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.352B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.306B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.300B | 0.00 |
| Brainsway (BWAY) | Israel | $0.294B | 59.85 |
| High Tide (HITI) | Canada | $0.292B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.287B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.286B | 21.68 |
| Omeros (OMER) | United States | $0.283B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.260B | 0.00 |
| Cerus (CERS) | United States | $0.251B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.242B | 0.00 |
| Organigram Global (OGI) | Canada | $0.232B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.219B | 0.00 |
| Exagen (XGN) | United States | $0.217B | 0.00 |
| Quanterix (QTRX) | United States | $0.211B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.199B | 16.63 |
| FitLife Brands (FTLF) | United States | $0.175B | 0.00 |
| Biote (BTMD) | United States | $0.170B | 5.64 |
| Jushi Holdings (JUSHF) | United States | $0.149B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.114B | 0.00 |
| MacroGenics (MGNX) | United States | $0.112B | 0.00 |
| Jin Medical (ZJYL) | China | $0.111B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.78 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Apyx Medical (APYX) | United States | $0.075B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.062B | 0.00 |
| MariMed (MRMD) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.059B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.059B | 0.00 |
| Zynex (ZYXI) | United States | $0.050B | 0.00 |
| Veru (VERU) | United States | $0.048B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 31.08 |
| United-Guardian (UG) | United States | $0.039B | 15.02 |
| Senestech (SNES) | United States | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Sharps Technology (STSS) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |